MSCMyron S. CohenMDSlidesetHIVRSVCOVID-19OncologyInternational Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021Monoclonal Antibodies for Prevention of HIV, COVID, and Ebola - Myron Cohen, MD, BSView Slideset
FAFlorence AderProf, MDSlidesetHIVRSVCOVID-19OncologyInternational Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021Monoclonal Antibodies for Treatment in COVID-19 - Florence Ader, Prof, MDView Slideset
BABrigitte AutranMD, PhDSlidesetHIVRSVCOVID-19OncologyInternational Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021Monoclonal Antibodies Against COVID-19: Targets, Development and Clinical Applications - Brigette Autran, MD, PhDView Slideset
CFCharles FlexnerMDSlidesetHIVRSVCOVID-19OncologyInternational Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021 - Historical Perspectives from Pasteur to Flexner: The Evolution of Serum to Monoclonal Antibody Therapy- Charles W. FlexnerView Slideset
JRJürgen RockstrohMDSlidesetHIVWeighty Matters in HIV Treatment 2021Weighty Matters in HIV Treatment 2021 - Incorporating ARV Weight Gain into Clinical Decisions - François VenterView Slideset
GMGrace McComseyMD, FIDSASlidesetHIVWeighty Matters in HIV Treatment 2021Weighty Matters in HIV Treatment 2021 - Clinical Case Presentation 2 - Focus on Women - Grace McComseyView Slideset
JRJürgen RockstrohMDSlidesetHIVWeighty Matters in HIV Treatment 2021Weighty Matters in HIV Treatment 2021 - Clinical Case Presentation 1 - Focus on Young MSM - Jürgen RockstrohView Slideset
JRKJohn Robert KoetheMD, MSCI, FIDSASlidesetHIVWeighty Matters in HIV Treatment 2021Weighty Matters in HIV Treatment 2021 - What are the Clinical Consequences of ARV Induced Weight Gain and Other Metabolic Toxicities? - John Robert KoetheView Slideset
LWLaura WatersMD, FRCPSlidesetHIVWeighty Matters in HIV Treatment 2021Weighty Matters in HIV Treatment 2021 - ARV Associated Weight Gain: What are the Possible Mechanisms? - Laura WatersView Slideset
AMGAnna Maria GerettiMD, PhD, FRCPathSlidesetHIVEuropean HIV Clinical Forum 2022Integrating Multiple Novel Agents for Optimal Care of Multiclass Resistant Patients - Anna Maria Geretti, MD, PhD, FRCPathView Slideset
EREmma RubensteinMD, MPHSlidesetHIVEuropean HIV Clinical Forum 2022Clinical Case - Emma Rubenstein, MD, MPHView Slideset
MPMiłosz ParczewskiMD, PhDSlidesetHIVEuropean HIV Clinical Forum 2022Clinical Case - Miłosz Parczewski, MD, PhDView Slideset
